Jagsonpal Pharmaceuticals Ltd.
Snapshot View

307.35 -0.35 ▼-0.1%

25 November 2022, 04:01:00 PM
Volume: 3,491

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jagsonpal.com
Market Cap 799.17 Cr.
Enterprise Value(EV) 754.75 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 6.19 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 49.30 Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 49.73 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.13 Calculated using Price: 305.05
Dividend Yield 1.31 Period Ending 2022-03
No. of Shares Subscribed 2.62 Cr. 26,198,000 Shares
FaceValue 5
Company Profile
In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar's vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India's premiere pharmaceutical companies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.11%
1 Week
-2.18%
1 Month
-13.41%
3 Month
-23.00%
6 Month
+7.54%
1 Year
+100.16%
2 Year
+382.50%
5 Year
+714.17%
10 Year
+2122.34%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.47 1.35 3.65 12.32 -12.01 7.72 7.88 15.70 16.52
Return on Capital Employed (%) 6.57 4.93 7.32 14.26 -10.52 9.80 9.46 19.43 22.64
Return on Assets (%) 1.37 0.75 2.08 7.86 -8.48 5.43 5.53 10.90 11.78

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 99 95 98 110 98 104 111 122 131 138
Non Curr. Liab. 4 4 4 3 3 3 3 2 3 6
Curr. Liab. 54 55 57 29 29 28 35 40 34 21
Minority Int.
Equity & Liab. 156 154 159 143 130 136 149 164 168 166
Non Curr. Assets 65 58 58 33 35 38 52 44 58 52
Curr. Assets 91 96 101 110 95 98 96 120 111 114
Misc. Exp. not W/O
Total Assets 156 154 159 143 130 136 149 164 168 166

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 144 138 143 144 127 167 159 188 226 228
Other Income 0 0 1 0 0 1 3 4 3 4
Total Income 144 138 144 144 127 168 161 192 229 231
Total Expenditure -133 -129 -132 -138 -138 -157 -150 -169 -200 -202
PBIDT 11 9 12 6 -11 11 11 23 29 29
Interest -5 -4 -5 -3 -1 -1 -1 -1 0 0
Depreciation -3 -3 -3 -2 0 -1 -1 -1 -2 -1
Taxation 0 -1 -1 -3 0 -2 -2 -5 -8 -6
Exceptional Items 13 -6
PAT 2 1 3 12 -12 7 8 17 20 16
Adjusted EPS 1 0 1 5 -4 3 3 7 7 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 12 8 4 9 -3 -2 31 12 28 6
Cash Fr. Inv. -3 -1 0 -2 41 -3 -1 -11 -2 -26
Cash Fr. Finan. -8 -4 -1 -6 -34 -1 -6 -2 -7 -12
Net Change 0 2 2 1 5 -6 24 -1 19 -33
Cash & Cash Eqvt 10 13 15 16 20 15 39 40 59 26

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 70.34 70.34 70.34 70.34 70.34 70.34 68.71 68.71 68.72
Public 29.66 29.66 29.66 29.66 29.66 29.66 31.29 31.29 31.28
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 24 Nov 2022
Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulations (Amendments) 2018.
Pursuant to Regulation 23(9) of the SEBI Listing Regulations please find enclosed herewith disclosures of related party transactions on consolidated basis in the revised format as prescribed under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22" November 2021 for the half year ended commencing from 01 April 2022 to 30 September 2022.
Wed, 09 Nov 2022
Board Meeting Outcome for OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON NOVEMBER 09TH 2022.
OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON NOVEMBER 09TH 2022.
Wed, 09 Nov 2022
Financial Results For The Quarter And Half Year Ended 30 September 2022.
Financial Results for the quarter and half year ended 30 September 2022.

Technical Scans View Details >>

Fri, 25 Nov 2022
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Increase 1 Year High Increase 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Jagsonpal Pharmaceuticals Ltd.

What is Jagsonpal Pharma share price?

Can I buy Jagsonpal Pharma shares now?

What is the Dividend Yield of Jagsonpal Pharma?

What is the Market Cap of Jagsonpal Pharma?

What are the key metrics to analyse Jagsonpal Pharma?

What is the 52 Week High and Low of Jagsonpal Pharma?

What is the trend of Jagsonpal Pharma share price?